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Abstracts / Urological Science 26 (2015) S1eS25 S13there were at least 600 papers investigating the contribution of individual
genomic variations to bladder cancer (26-30), while few to UTUC (7, 31,
32). Following the rule of molecular central dogma, the single nucleotide
variations on COX-2 among people may determine their differential
expression of COX-2 and personal susceptibility to cancers. The supporting
data comes from that COX-2 is often undetectable in normal tissues,
whereas overexpression of COX-2 has been observed in neoplastic cells of
canine (33) and human RCC (34-36). In our previous report, COX-2 was
found to be up-regulated in both stromal and tumor cells of more than half
of the UTUC patients and the positive expression of COX-2 in stromal cells
may be a biomarker for UTUC-speciﬁc death and recurrence (10). However,
the contribution of COX-2 genotypes to UTUC has never been studied. In
this study, the genotypes of COX-2 of 218 UTUC patients together with 580
controls (Table III) were examined. Statistically, the distributions of COX-2
genotypes for G-765C and intron 5 were differentially distributed among
the UTUC and healthy control groups (Table III). In addition, the allelic
frequencies of the two polymorphisms were also differentially distributed
between the two groups (Table IV). The results showed that the G allele of
G-765C and A allele of intron 5 were associated with higher risk for UTUC
and the haplotype analysis suggested that individuals with GG/AT and CG/
TT haplotypes at G-765C/intron 5 were at altered risk of UTUC before and
after adjusting of gender and age (Table V). UTUC is not a common cancer
in Taiwan and the world, which may be one of the limitation for genomic
study of UTUC. Compared with previous ﬁnding, we have enlarged the
sample size from 56 cases and 436 controls in 2011 (37) to 218 cases and
580 controls (Table II). The strengthened sample size and the same trend of
signiﬁcant genotype distribution after age and gender adjustments high-
lighted the value, accuracy and reliability of the overall ﬁndings (Table V).
This is the ﬁrst UTUC genomic study showing COX-2 G-765C and intron 5
genotypes were associated with UTUC risk. The G allele of Cox-2 G-765C and
A allele of COX-2 intron 5 were genomic risk factors and may serve as early
screening and prediction biomarkers for UTUC in Taiwan and all over the
world.
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Purpose: Urothelial carcinoma (UC) is common in urinary bladder (UB)
and upper urinary tract (UT). It represents a heterogeneous disease with
high morbidity and mortality. Tumor invasion and progression are a
multifactorial process promoted by microenvironmental changes that
include overexpression of matrix metalloproteinases (MMPs). Through
data mining from a published transcirptomic database of UBUCs
(GSE32894), MMP11 was identiﬁed as the most signiﬁcant gene showing
stepwise upregulation among those associated with the regulation of
metalloendopeptidase activity. We therefore analyze MMP11 protein
expression and its association with clinicopathological factors and sur-
vivals in our well-characterized cohort of UC.
Materials andMethods: Immunohistochemistry evaluated by usingH-score
was used to determine MMP11 protein expression in 295 UBUCs and 340
UTUCs, respectively. The medical records of these patients were reviewed
retrospectively. The MMP11 expression status was further correlated with
clinicopathological features as well as disease-speciﬁc survival (DSS) and
metastasis-free survival (MeFS). Univariate and multivariate statistical ana-
lyses were performed to evaluate the prognostic predictors.Results: MMP11 protein overexpression was signiﬁcantly associated with
advanced pT status (UTUC, p<0.001; UBUC, p<0.001), nodal metastasis
(UTUC, p<0.001; UBUC, p ¼ 0.012), vascular invasion (UTUC, p<0.001;
UBUC, p<0.001) and perineural invasion (UTUC, p ¼ 0.002; UBUC,
p¼ 0.006) in both groups of UC. MMP11 overexpression not only predicted
worse DSS (UTUC, p<0.0001; UBUC, p<0.0001) and MeFS (UTUC,
p<0.0001; UBUC, p<0.0001) at univariate analysis, but implicated inferior
DSS (UTUC, p¼ 0.005; UBUC, p¼ 0.010) andMeFS (UTUC, p¼ 0.018; UBUC,
p ¼ 0.026) in multivariate analysis.
Conclusion: MMP11 overexpression is associated with more aggressive
tumor phenotype and poor prognosis for both patients with UTUC and
UBUC, suggesting it may serve as a potential prognostic and a novel
therapeutic target of UC.
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Purpose: Galactin-1 plays an important role in oncogenic processes. In
several literatures, it has been studied that Galactin-1 is highly related to
some cancers, including hepatocellular carcinoma and breast cancer. In our
present study, we try to clarify the relationship between Galactin-1 over-
expression and prognosis of urinary bladder urothelial carcinoma (UC).
Materials and Methods: We reviewed 185 patients who had bladder UC
and received transurethral resection of bladder tumor. The spacemen was
re-examed by pathologist and further survey about cytoplasmic galactin-1
immunoexpression was performed. Then we correlate the laboratory data
to clinical disease prognosis under statistical analyses.
Results: Positive galectin-1 immunoexpression in tumor signiﬁcantly links
with increment of pT status (p ¼ 0.0295) as well as histological grade
(p ¼ 0.037), the presence of vascular invasion (p ¼ 0.0287), nodal status
(p ¼ 0.0012), high mitotic activity (p ¼ 0.0015) and tumor necrosis
(p ¼ 0.0246). Galectin-1 over-expression in tumor cell predicts the dis-
ease-speciﬁc survival in univariate (P ¼ 0.0002) and multivariate analysis
(P ¼ 0.03, HR ¼ 2.438). Besides, gene of galactine-1 (as LGALS1 gene)
ampliﬁcation is also linked to disease-speciﬁc survival rate (P ¼ 0.0006).
Conclusion: Galectin-1 over-expression is an adverse factor to predict the
prognosis of urinary bladder UC. It may help us about clinical decision
making and outcome prediction. Further relationship between urinary
bladder UC and galactin-1 can be studied on the base of this present study.
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Purpose: Cancer cells adapt to the stress resulting from accelerated cells
growth, lack of nutrients or challenges of anti-cancer drugs by activation of
the autophagy pathway. We demonstrated that human bladder cancer cells
exhibit high level of basal autophagy in our previous studies. We therefore
hypothesize that autophagy inhibitors such as chloroquine (CQ) and
hydroxychloroquine (HCQ) that inhibits autophagosome functionwill result
in cancer cell death by induction of apoptosis in human bladder cancer cells.
Materials and Methods: Human Immortalized uroepithelial cell, SV-Huc-
1; human bladder cancer cells including: transitional cell carcinoma (TCC)
grade I, RT-4; TCC grade II, 5637; TCC grade III, T24; human prostate cancer
